Connect Sign In
LabMind podcasts
Jonathan Genzen, MD, PhD, MBA, ARUP’s chief medical officer and senior director of governmental affairs, said the Enhancing CLIA Act is an intriguing step forward in considering future oversight of laboratory-developed tests. |
June 16, 2026 |
Clinical Labs Review Proposed Legislation To Modernize Oversight of Lab-Developed Tests Under CLIA Newly introduced federal legislation would modernize oversight of lab-developed tests under the Clinical Laboratory Improvement Amendments but support innovation, transparency, and patient access. |
Accurate and timely diagnosis is critical to guiding appropriate treatment and improving patient outcomes. |
June 16, 2026 |
Navigating Tickborne Disease Testing Amid Rising U.S. Tick Activity Tick activity has traditionally peaked during the warmer months but that seasonal window appears to be expanding. Changing climate patterns resulting in milder winters are allowing more ticks to survive, contributing to earlier emergence in the spring. |
Clinicians should coordinate with local health departments for assistance with testing for suspected Andes hantavirus and Ebola Bundibugyo infections. |
June 10, 2026 |
ARUP Laboratories Monitors Andes Hantavirus and Ebola Outbreaks to Assess Laboratory Testing Needs Benjamin Bradley, MD, PhD, discusses the current risk of Andes hantavirus and Ebola Bundibugyo in the U.S., ARUP’s response, and testing recommendations. |
Foodborne illness can take hold quickly and often presents with acute gastrointestinal (GI) symptoms. |
June 4, 2026 |
ARUP Launches Bacterial Gastrointestinal Panels for Rapid Results and Faster Reporting ARUP has launched multiplex polymerase chain reaction bacterial gastrointestinal panels that detect common pathogens with faster turnaround times to support rapid diagnosis and public health response. |
ARUP experts will share their latest research, including a deep dive on arthropods, drug resistance in mycobacterium, and same-shift diagnostic testing. |
June 1, 2026 |
From Arthropods to Antimicrobial Resistance: ARUP at ASM Microbe 2026 Join ARUP experts at the American Society for Microbiology (ASM) Microbe 2026 conference for their latest research presentations, topic deep dives, and more. |
From left to right, Toni Pollock, director of PharmaDx; Margaret Coppin, HT(ASCP), chief quality officer; Tracy George, MD, chief scientific officer and president of ARUP’s Innovation Business Unit; Sarah Teofilo, chief information officer; Erica Clyde, MBA, PMi-PMP®, MB(ASCP)CM, director of the ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™; and Ligaya Kuiken, MBA, MLS(ASCP)CM, MB(ASCP)CM, ARUP Human Resources education program coordinator, celebrate George’s selection as one of the 2026 Top 10 Influential Women by Utah Business magazine at a luncheon honoring the Women To Watch nominees. |
May 21, 2026 |
Tracy George, MD, Named One of the Top 10 Influential Women by Utah Business Magazine Tracy George, MD, has been named one of the Top 10 Influential Women by Utah Business magazine, recognizing her leadership in advancing diagnostic innovation, science, and patient care. |
ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ We accelerate the development and adoption of cutting-edge diagnostic and prognostic technologies advancing patient care through groundbreaking science and engineering. The Sherrie Perkins Research and Innovation Collaboration Grant The Sherrie Perkins Research and Innovation Collaboration Grant funds cutting-edge research in laboratory medicine.
ARUP Newsroom
Live Chat